NCT05965375

Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias

Name: Clinical Trial NCT05965375
Creator: First Affiliated Hospital Xi'an Jiaotong University
Keywords: Ventricular Arrythmia, Observational; No Interventions were given., other, clinical trial, China

Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias (FUTURE): an Investigator-initiated, National, Multicenter, Retrospective-prospective, Cohort Study

First Affiliated Hospital Xi'an Jiaotong University·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Ventricular Arrythmia
Drug/Device/Intervention: Observational; No Interventions were given.
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: First Affiliated Hospital Xi'an Jiaotong University
Location: Xi'an, China

Timeline & enrollment

Phase: N/A
Start date: Oct 31, 2023
End date: May 31, 2027
Enrollment: 5000 participants

Primary outcome

Change in the incidence of MACCE

Summary

The investigation of biomarkers for immune status and metabolic state, as well as host microbiota composition, in patients with ventricular arrhythmias before and after radiofrequency ablation, can provide new insights for specific and personalized treatment. This can help establish early prediction and prognosis models and provide a basis for clinically effective diagnosis and treatment.

ICD-10 classifications

Ventricular tachycardiaLeft ventricular failureVentricular septal defectCardiomyopathy, unspecifiedCardiac arrhythmia, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05965375
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05965375 through Pure Global AI's free database. This phase not specified trial is sponsored by First Affiliated Hospital Xi'an Jiaotong University and is currently Not yet recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 5000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.